Effect of the functional drink containing Kaempferia parviflora as ingredient on physical performance and mental health of working age volunteers

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

TCTR

Registry ID

TCTR20210528002

Enrollment

Registered

2021-05-28

Start date

2021-08-03

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy conditions Kaempferia parviflora physical performance mental health working age

Interventions

Subjects are received the placebo product which has same color and smell look like functional drink containing Kaempferia parviflora.,Subjects are received functional drink containing Kaempferia parv

Placebo Comparator Other,Experimental Dietary Supplement,Experimental Dietary Supplement

Placebo,Functional drink containing Kaempferia parviflora 90 mg/day,Functional drink containing Kaempferia parviflora 180 mg/day

Eligibility

Sex/Gender

All

Age

19 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Aged between 19-60 years old 2. Body Mass Index (BMI) between 18.5-25 kg/m2

Exclusion criteria

Exclusion criteria: 1.Volunteers who have been diagnosed with one of the following; diabetes mellitus, cardiovascular diseases , liver disease, kidney disease, respiratory diseases, autoimmune disease and neuropsychological diseases 2.Volunteers who require supplements or any drug that effect on the nervous system by order of the doctor before trial 3.Volunteers who use hormone or any drug that effect on the nervous system during 2 month before the test 4.Smoking more than 10 pieces/ day 5.Drinking alcohol more than 5 times/ day 6.Volunteers who participate in other projects

Design outcomes

Primary

Measure	Time frame
Physical performance 12 weeks Physical fitness test	—

Secondary

Measure	Time frame
The changes of hematological and clinical chemistry 12 weeks Laboratory,Acetylcholinesterase, Choline acetyltransferase and Monoamine oxidase 12 weeks Laboratory,Oxidative stress markers include Malondialdehyde (MDA), Superoxide dismutase (SOD), Catalase (CAT) and Glutathione peroxidase (GSH-Px) 12 weeks ELISA method,Inflammatory markers include TNF-alpha, IL-6, NF-kB and CRP 12 weeks ELISA method,Electrocardiogram 12 weeks Equipment,Body Composition, Body Mass Index, Body fat ratio and Muscle mass 12 weeks Equipment,Working memory test 12 weeks Computerized battery test,Psychological evaluation 12 weeks GHQ-28 questionnaire	—

Measure

Time frame

The changes of hematological and clinical chemistry 12 weeks Laboratory,Acetylcholinesterase, Choline acetyltransferase and Monoamine oxidase 12 weeks Laboratory,Oxidative stress markers include Malondialdehyde (MDA), Superoxide dismutase (SOD), Catalase (CAT) and Glutathione peroxidase (GSH-Px) 12 weeks ELISA method,Inflammatory markers include TNF-alpha, IL-6, NF-kB and CRP 12 weeks ELISA method,Electrocardiogram 12 weeks Equipment,Body Composition, Body Mass Index, Body fat ratio and Muscle mass 12 weeks Equipment,Working memory test 12 weeks Computerized battery test,Psychological evaluation 12 weeks GHQ-28 questionnaire

—

Countries

Thailand

Contacts

Public ContactJintanaporn Wattanathorn

Khon Kaen University

jinwat@kku.ac.th0818721809

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026